The table below shows Bio-Rad Laboratories, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$108.10M
$129.90M
$69.80M
$98.12M
$50.49M
$113.61M
Capital expenditure
$30.00M
$34.40M
$40.20M
$35.73M
$33.08M
$19.55M
Investing cash flow
-$93.20M
$2.90M
-$43.10M
-$70.47M
-$916.14M
-$48.33M
Dividends paid
-
-
-
-
-
BIO operating cash flow (10-K history)
Bio-Rad Laboratories, Inc. reported operating cash flow of $532.20M for fiscal year 2025. That is up 16.9% from $455.20M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $216.07M (FY 2016) to $532.20M. Figures come from the company's audited annual reports as filed with the SEC.
